DNA prime-protein boost immunization in monkeys: Efficacy of a novel construct containing functional domains of Plasmodium cynomolgi CS and TRAP

FEMS Immunology and Medical Microbiology

Volumn 39, Issue 3, 2003, Pages 241-250

  Bhardwaj, Devesh ^a   Kushwaha, Ashima ^a   Puri, Sunil Kumar ^b   Herrera, Antonieta ^a   Singh, Naresh ^a   Chauhan, Virander Singh ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Circumsporozoite protein; DNA vaccine; Malaria; Prime boost; Thrombospondin related adhesive protein

Indexed keywords

CIRCUMSPOROZOITE PROTEIN, PROTOZOAN; DNA VACCINE; GAMMA INTERFERON; MALARIA VACCINE; NAKED DNA; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN; THROMBOSPONDIN RELATED ADHESIVE PROTEIN, PROTOZOAN; THROMBOSPONDIN-RELATED ADHESIVE PROTEIN, PROTOZOAN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CARBOXY TERMINAL SEQUENCE; CELL ACTIVITY; CELL DIVISION; CELL PROLIFERATION; CELLULAR IMMUNITY; CHIMERA; CONTROLLED STUDY; CYTOLOGY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOLOGY; LYMPHOCYTE; MACACA; MALARIA; MALE; METHODOLOGY; MOLECULAR GENETICS; MOUSE; MOUSE STRAIN; NONHUMAN; PARASITEMIA; PLASMODIUM CYNOMOLGI; PRIORITY JOURNAL; RANDOMIZATION; RHESUS MONKEY; SPOROZOITE; STANDARD; T LYMPHOCYTE; VACCINATION;

EID: 0345447538     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00227-X     Document Type: Article

References (35)

1. Nussenzweig, V. and Nussenzweig, R.S. (1990) Progress toward a malaria vaccine. Hosp. Pract. (Off. Ed.) 25, 45-52, 55-47.
2. Schofield L., Villaquiran J., Ferreira A., Schellekens H., Nussenzweig R.S., Nussenzweig V. γ-Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature. 330:1987;664-666.
3. Doolan D.L., Hoffman S.L. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165:2000;1453-1462.
4. Nussenzweig V., Nussenzweig R.S. Circumsporozoite proteins of malaria parasites. Cell. 42:1985;401-403.
5. Gantt S.M., Clavijo P., Bai X., Esko J.D., Sinnis P. Cell adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG. J. Biol. Chem. 272:1997;19205-19213.
6. Robson K.J.H., Frevert U., Reckman I., Cowan G., Beier J., Scragg I.G., Takehara K., Bishop D.H.L., Pradel G., Sinden R., Saccheo S., Muller H.M., Crisanti A. Thrombospondin related adhesive protein (TRAP) of Plasmodium falciparum expression during sporozoites ontogeny and binding to human hepatocytes. EMBO J. 14:1995;3883-3894.
7. Sultan A.A., Thathy V., Frevert U., Robson K.J., Crisanti A., Nussenzweig V., Nussenzweig R.S., Menard R. TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites. Cell. 90:1997;511-522.
8. Chatterjee S., Wery M., Sharma P., Chauhan V.S. A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge. Infect. Immun. 63:1995;4375-4381.
9. Bharadwaj A., Sharma P., Joshi S.K., Singh B., Chauhan V.S. Induction of protective immune responses by immunization with linear multiepitope peptides based on conserved sequences from Plasmodium falciparum antigens. Infect. Immun. 66:1998;3232-3241.
10. Romero P., Maryanski J.L., Corradin G., Nussenzweig R.S., Nussenzweig v., Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature. 341:1989;323-325.
11. Hill A.V., Elvin J., Willis A.C., Aidoo M., Allsopp C.E., Gotch F.M., Gao X.M., Takiguchi M., Greenwood B.M., Townsend A.R., et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature. 360:1992;434-439.
12. Nardin E.H., Nussenzweig R.S. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development. Annu. Rev. Immunol. 11:1993;687-727.
13. Aidoo M., Lalvani A., Allsopp H.P., Plebanski M., Meisner S.J., Krausa P., Browning M., Morris-Jones S., McAdam S., Gotch F., Fidock D.A., Takiguchi M., Robson K.J.H., Greenwood B.M., Druihle P., Whittle H.C., Hill A.V.S. Identification of conserved antigenic componens for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet. 345:1995;1003-1007.
14. Dolo A., Modiano D., Doumbo O., Bosman A., Sidibe T., Keita M.M., Naitza S., Robson K.J., Crisanti A. Thrombospondin related adhesive protein (TRAP), a potential malaria vaccine candidate. Parasitologia. 41:1999;425-428.
15. Nardin E., Zavala F., Nussenzweig V., Nussenzweig R.S. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials. Parasitologia. 41:1999;397-402.
16. Ulmer J.B. An update on the state of the art of DNA vaccines. Curr. Opin. Drug Discov. Dev. 4:2001;192-197.
17. Doolan D.L., Hoffman S.L. DNA-based vaccines against malaria: status and promise of the multi-stage DNA vaccine operation. Int. J. Parasitol. 31:2001;753-762.
18. Sedegah M., Hedstrom R., Hobart P., Hoffman S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA. 91:1994;9866-9870.
19. Sedegah M., Jones T.R., Kaur M., Hedstrom R., Hobart P., Tine J.A., Hoffman S.L. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc. Natl. Acad. Sci. USA. 95:1998;7648-7653.
20. Schneider J., Gilbert S.C., Blanchard T.J., Hanke T., Robson K.J., Hannan C.M., Becker M., Sinden R., Smith G.L., Hill A.V. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4:1998;397-402.
21. Rogers W.O., Baird J.K., Kumar A., Tine J.A., Weiss W., Aguiar J.C., Gowda K., Gwadz R., Kumar S., Gold M., Hoffman S.L. Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques. Infect. Immun. 69:2001;5565-5572.
22. Letvin N.L., Montefiori D.C., Yasutomi Y., Perry H.C., Davies M.E., Lekutis C., Alroy M., Freed D.C., Lord C.I., Handt L.K., Liu M.A., Shiver J.W. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. USA. 94:1997;9378-9383.
23. Jones T.R., Narum D.L., Gozalo A.S., Aguiar J., Fuhrmann S.R., Liang H., Haynes J.D., Moch J.K., Lucas C., Luu T., Magill A.J., Hoffman S.L., Sim B.K. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen. J. Infect. Dis. 183:2001;303-312.
24. Escalante A.A., Ayala F.J. Phylogeny of the malarial genus Plasmodium, derived from rRNA gene sequences. Proc. Natl. Acad. Sci. USA. 91:1994;11373-11377.
25. Bhardwaj D., Hora B., Singh N., Puri S., Lalitha P., Rupa P., Chauhan V. Immunogenicity and protective efficacy of three DNA vaccines encoding pre-erythrocytic- and erythrocytic-stage antigens of Plasmodium cynomolgi in rhesus monkeys. FEMS Immunol. Med. Microbiol. 34:2002;33-43.
26. Sijwali P.S., Malhotra P., Puri S.K., Chauhan V.S. Cloning and sequence analysis of the thrombospondin-related adhesive protein (TRAP) gene of Plasmodium cynomolgi bastianelli. Mol. Biochem. Parasitol. 90:1997;371-376.
27. Luke C.J., Carner K., Liang X., Barbour A.G. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J. Infect. Dis. 175:1997;91-97.
28. Hartmann G., Weeratna R.D., Ballas Z.K., Payette P., Blackwell S., Suparto I., Rasmussen W.L., Waldschmidt M., Sajuthi D., Purcell R.H., Davis H.L., Krieg A.M. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164:2000;1617-1624.
29. Earle W.S., Perez M. Enumeration of parasites in the blood of malarial patients. J. Lab. Clin. Med. 17:1932;1124-1131.
30. Bhardwaj D., Singh S.S., Abrol S., Chaudhary V.K. Monoclonal antibodies against a minor and the major coat proteins of filamentous phage M13: their application in phage display. J. Immunol. Methods. 179:1995;165-175.
31. Heppner D.G., Gordon D.M., Gross M., Wellde B., Leitner W., Krzych U., Schneider I., Wirtz R.A., Richards R.L., Trofa A., Hall T., Sadoff J.C., Boerger P., Alving C.R., Sylvester D.R., Porter T.G., Ballou W.R. Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes. J. Infect. Dis. 174:1996;361-366.
32. Engers H.D., Godal T. Malaria vaccine development: Current status. Parasitol. Today. 14:1998;56-64.
33. Sauzet J.-P., Perlaza B.-L., Brahimi K., Daubersies P., Druilhe P. DNA immunisation by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge. Infect. Immun. 69:2001;1202-1206.
34. Sharma P., Bharadwaj A., Bhasin V.K., Sailaja V.N., Chauhan V.S. Antibodies to a conserved-motif peptide sequence of the Plasmodium falciparum thrombospondin-related anonymous protein and circumsporozoite protein recognize a 78-kilodalton protein in the asexual blood stages of the parasite and inhibit merozoite invasion in vitro. Infect. Immun. 64:1996;2172-2179.
35. Wang R., Doolan D.L., Le T.P., Hedstrom R.C., Coonan K.M., Charoenvit Y., Jones T.R., Hobart P., Margalith M., Ng J., Weiss W.R., Sedegah M., de Taisne C., Norman J.A., Hoffman S.L. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science. 282:1998;476-480.